INDEVUS PHARMACEUTICALS INC 4

4 · INDEVUS PHARMACEUTICALS INC · Filed Dec 8, 2008

Form 4

Period: 2008-12-04

Director

Transactions

Award
Stock Option (right to buy)
2008-12-04+31,000→ 31,000 total
Exercise: $6.19Exp: 2010-06-10→ Common Stock, $.001 par value per share (31,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2008-12-04−31,000→ 0 total
Exercise: $6.19Exp: 2009-06-10→ Common Stock, $.001 par value per share (31,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2008-12-04−5,000→ 0 total
Exercise: $3.63Exp: 2009-03-17→ Common Stock, $.001 par value per share (5,000 underlying)
Award
Stock Option (right to buy)
2008-12-04+5,000→ 5,000 total
Exercise: $3.63Exp: 2010-03-17→ Common Stock, $.001 par value per share (5,000 underlying)

Footnotes (3)

[F1]All of the reported transactions involved the amendment of outstanding stock options to extend the respective expiration dates from 6/10/2009 to 6/10/2010 and from 3/17/2009 to 3/17/2010; such extensions are considered by the Securities and Exchange Commission to be cancellations of the current stock options.
[F2]Prior to the extension of the current stock option, such stock option was fully exercisable.
[F3]This stock option is fully exercisable as of the date of this report.

Documents

1 file